Drug intelligence / Profile preview

vancomycine + héparine

Development stage
Unknown
Lead developer
Xellia Pharmaceuticals
Modality
Small Molecules, Cyclic Peptides → Modified Peptides → Peptides, Antimicrobial Peptides → Native Peptides → Peptides
Administration
Intravenous, Intracatheter
01

Overview

This is a combination of two drugs, vancomycin and heparin. - **Vancomycin** is a glycopeptide antibiotic that inhibits bacterial cell wall synthesis by binding to the D-Ala-D-Ala terminus of cell wall precursor units, leading to bactericidal activity against many Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). It may also alter membrane permeability and selectively inhibit RNA synthesis[5][7]. - **Heparin** is an anticoagulant that potentiates the action of antithrombin III, thereby inhibiting thrombin and factor Xa activity in the coagulation cascade. This prevents clot formation. The combination may be used in clinical settings such as catheter lock solutions or parenteral nutrition admixtures to provide both antibacterial protection (from vancomycin) and prevention of catheter thrombosis (from heparin)[4]. Both agents retain their respective activities when combined in dilute solution[4]. However, physical incompatibility can occur at higher concentrations or if mixed improperly; precipitation has been reported when administered through the same tubing[3][9].

Other names
vancomycin + heparinvancomycine et héparine
02

Targets

ATIII (Antithrombin III)D-Ala-D-Ala (D-Ala-D-Ala terminus)

Beyond the preview

Go deeper on vancomycine + héparine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on vancomycine + héparine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call